Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment.
Long-term administration of antipsychotic drugs can induce differential expression of a variety of genes in the brain, which may underscore the molecular mechanism of the clinical efficacy and/or side effects of antipsychotic drugs. We used cDNA microarray analysis to screen differentially expressed genes in rat frontal cortex under 4 weeks' treatment of risperidone (1 mg/kg). Using real-time quantitative PCR, we were able to verify eight genes, whose expression were significantly upregulated in rat frontal cortex under chronic risperidone treatment when compared with control animals. These genes include receptor for activated protein kinase C, amida, cathepsin D, calpain 2, calcium-independent receptor for alpha-latrotoxin, monoamine oxidase B, polyubiquitin, and kinesin light chain. In view of the physiological function of these genes, the results of our study suggest that chronic risperidone treatment may affect the neurotransmission, synaptic plasticity, and proteolysis of brain cells. This study also demonstrates that cDNA microarray analysis is useful for uncovering genes that are regulated by chronic antipsychotic drugs treatment, which may help bring new insight into the molecular mechanism of antipsychotic drugs.
Chen
Mao-Liang
ML
Institute of Medical Sciences, Tzu-Chi University, Hualien City, Taiwan.
Chen
Chia-Hsiang
CH
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D017931:DNA Primers; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D003851:Deoxyribonucleases / Q000737:chemistry; D015870:Gene Expression / Q000187:drug effects*; D017403:In Situ Hybridization; D008297:Male; D008969:Molecular Sequence Data; D020411:Oligonucleotide Array Sequence Analysis; D016376:Oligonucleotides, Antisense; D017397:Prefrontal Cortex / Q000378:metabolism*; D011786:Quality Control; D012313:RNA / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018967:Risperidone / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects
D014150:Antipsychotic Agents; D017931:DNA Primers; D018076:DNA, Complementary; D016376:Oligonucleotides, Antisense; D012313:RNA; D003851:Deoxyribonucleases; D018967:Risperidone